Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (16,048)	$ (25,818)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	4	4
Stock-based compensation	443	1,590
Common stock issued in exchange for services	37	0
Change in fair value of warrant liabilities	(174)	(27)
Change in fair value of convertible promissory notes	(1,011)	2,794
Loss on convertible note redemptions	127	0
Expense for debt issuance costs due to fair value election on Anson Notes	521	0
Warrant issuance costs related to Alvogen termination	1,336	0
Convertible note default penalty	849	0
Non-cash settlement expense	0	250
Changes in operating assets and liabilities:
Prepaid expense and other assets	(100)	1,554
Accounts payable	4,949	1,654
Insurance loan payable	634	0
Accrued expense and other liabilities	(106)	(466)
Net cash used in operating activities	(8,539)	(18,465)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of computer equipment	0	(4)
Net cash used in investing activities	0	(4)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayment of convertible note	(4,800)	(2,288)
Repayment of insurance note	0	(474)
Expense for debt issuance costs due to fair value election on Anson Notes	(521)	0
Proceeds from issuance of insurance loan	0	786
Proceeds from Anson convertible note, net	2,941	0
Proceeds from liability classified warrants	2,059	0
Proceeds from issuance of Series A preferred stock and warrants issued in private placement, net of issuance costs	0	1,171
Proceeds from issuance of common stock and warrants, net of issuance costs	4,884	0
Proceeds from issuance of common stock and warrants issued in private placement, net of issuance costs	1,027	8,122
Net cash provided by financing activities	5,590	7,317
Net decrease in cash and cash equivalents	(2,949)	(11,152)
Cash and cash equivalents at beginning of period	4,595	20,054
Cash and cash equivalents at end of period	1,646	8,902
Supplemental disclosure of cash flow information:
Cash paid for interest	374	646
Cash paid for taxes	0	0
Non-cash investing and financing activities:
Issuance of common stock warrants as offering costs	188	75
Issuance of common stock for settlement of accrued liability	0	250
Conversion of Series A Preferred Stock to Common stock [Member]
Non-cash investing and financing activities:
Conversion of Series A preferred stock into common stock	3	0
Conversion of Principal and Interest Into Common Stock [Member]
Non-cash investing and financing activities:
Issuance of common stock as principal and interest repayment for convertible notes	$ 1,102	$ 982